The curated BIO-Europe Spring programme brings together a powerhouse of thought leaders and features the innovative spirit of the life sciences community. Here is a sneak peek at what to expect.
Too often in discussions about the COVID-19 pandemic it is treated like a finished and finalised event. Anu Osinusi at Gilead Sciences explores how its impacts are still being felt by patients and healthcare organisations around the globe.
Julie Missaggia at CMI Media Group, a WPP Company, and Compas, explores how workplaces engage with the symptoms of menopause, and how this can be improved.
In Pharmafocus’ inaugural Leader in Focus feature, Şeyda Atadan Memiş at Takeda UK and Ireland reflects on her career and explains the importance of providing more support to get women involved in STEM.
With a region as large and diverse as Europe, Mike Ryan and Paolo Correale at EVERSANA explain how pharma companies can best engage with the myriad of expectations and regulations associated with launching in the EU.
Pharmafocus outlines some top-level stats on women’s health in the UK, helping to contextualise the expert industry insights featured in this issue.
Page 4 – EDX Medical reveals new test for prostate cancer.
Page 7 – Emalex Bioscience’s candidate for Tourette syndrome meets phase 3 endpoints.
Page 9 – MHRA approves Telix’s prostate cancer imaging agent Illuccix.
Page 10 – Rznomics confirms FDA Fast Track designation for liver cancer treatment.
Page 13– Solventum’s purification and filtration business sold to Thermo Fisher Scientific for $4.1bn.
Page 14 – Novo Nordisk UK appoints Sebnem Avsar Tuna as general manager.
Executive Director
PMGroup Worldwide Ltd
Karl Equi
Group Managing Editor
Iona Everson
Editors
Charlie Blackie-Kelly
charlie@samedanltd.com
James Spargo
james@samedanltd.com
Deputy Editor
Emily Kimber
ekimber@pmlive.com
Business Manager
Louise Wilson-English
louise@samedanltd.com
Design & Layout
Peter May
Pharmafocus is published by:
Samedan Ltd
44 Maiden Lane, London
WC2E 7LN
Tel: +44 (0)20 7724 3456
Fax: +44 (0)20 7403 7747
Subscriptions & Data Management
Curwood CMS Tel: 01580 883840
ISSN: 1465-5403
Pharmafocus is sent free of charge to selected permanent employees of ethical and OTC pharmaceutical and biotech companies. Employees are specifiers from middle and senior management with responsibility for making buying decisions. Selection is at the discretion of the Publisher. Copies are also available on a subscription basis at an annual fee of £115 (UK), £145 (Europe) and £185 (RoW).
All subscriptions payable to Samedan. Back copies can be purchased for £15.00 each. Pharmafocus is published by Samedan Ltd. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form without permission, unless for the purposes of reference and comment.
©2025 Samedan Ltd, Pharmaceutical Publishers
The opinions and views expressed by contributors to this publication are not necessarily those of the Editor or the Publisher and, while every care has been taken in the preparation of the newspaper, the Editor and the Publisher are not responsible for such opinions and views, or for any inaccuracies in the articles. The Publisher is not responsible for any images supplied by contributors. While every care is taken with artwork supplied, the Publisher cannot be held responsible for any loss or damage incurred. The entire content of this publication is protected by copyright. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form, by any means – electronic, mechanical, photocopying or otherwise – without the prior permission of the Publisher.